Dishman Pharma shares up over 5% on board's nod for bonus

Shares of Dishman Pharmaceuticals and Chemicals surged over 5 per cent today after the company's board approved a bonus issue of equity shares.
The stock jumped 5.34 per cent to settle at Rs 321.60 on BSE. During the day, it surged 14.64 per cent to Rs 350.
On NSE, shares of the company climbed 5.36 per cent to end at Rs 322.20.
The company added Rs 132.22 crore to Rs 2,595.22 crore in market valuation.
On the volume front, 9.63 lakh shares of the company changed hands at BSE and over 49 lakh shares were traded at NSE during the day.

Dishman Pharmaceuticals and Chemicals today said its board has approved amalgamation of Dishman Care Ltd (DCL), a wholly-owned subsidiary, with the company.

The board has also given nod to amalgamation of the firm with Carbogen Amcis India Ltd (CAIL), its subsidiary, Dishman Pharmaceuticals and Chemicals Ltd (DPCL) said in a BSE filing.
In a separate filing, DPCL said the board has approved bonus issue of equity shares in the ratio of one equity share for every one equity share held in the company, it added.
The board has also given nod to slump sale of effluent treatment plants (ETP) undertaking from the company to CAIL as a going concern and changing the name of CAIL to Dishman Carbogen Amcis Ltd, Dishman Pharmaceuticals and Chemicals (DPCL) said.

The total consideration for transfer of the ETP undertaking shall be Rs 15 crore, it added.